To understand whether the PPAR-γ agonist, thiazolidinedione, regulates the expression levels of PGC-1α, resulting in improved mitochondria function, we used both in vitro and in vivo MPP+/MPTP PD models. The gene discussed is PPARGC1A; the disease is Parkinson disease.